Journal of Blood Pressure

Journal of Blood Pressure

Journal of Blood Pressure – Membership

Open Access & Peer-Reviewed

Submit Manuscript

Advancing Cardiovascular Research in Blood Pressure and Hypertension

Join a global network of cardiologists, clinical researchers, and vascular specialists advancing understanding of blood pressure regulation, hypertension mechanisms, and cardiovascular outcomes. Membership provides predictable publishing costs, expert peer review from cardiovascular specialists, and worldwide visibility for your critical research in this essential field of medicine.

45% APC Savings
14 days Fast Decision
190+ Countries
100% Peer Reviewed
Peer Reviewed Expert Evaluation
Open Access Free to Read
DOI Assigned Permanent Citation
Indexed Discoverable
Archived Long-term Preserved

About the Journal

The Journal of Blood Pressure is a peer-reviewed, open access publication dedicated to publishing original research, clinical studies, and systematic reviews focused on blood pressure regulation, hypertension pathophysiology, cardiovascular outcomes, and antihypertensive therapies. Our scope encompasses essential and secondary hypertension, blood pressure variability, target organ damage, resistant hypertension, lifestyle interventions, and pharmacological treatments that improve patient outcomes and quality of life.

Our distinguished editorial board includes cardiologists, hypertension specialists, vascular medicine researchers, and clinical pharmacologists from leading cardiovascular centers and research institutions worldwide. We welcome randomized controlled trials, observational studies, meta-analyses, translational research, and health services research that advances our understanding of blood pressure management and reduces the global burden of cardiovascular disease affecting millions of patients.

We maintain rigorous methodological and ethical standards for all submissions. Authors must provide complete trial registration details, institutional ethics approvals, informed consent documentation, and transparent conflict of interest disclosures. We encourage adherence to CONSORT for clinical trials and PRISMA for systematic reviews. Membership never influences editorial decisions; all manuscripts undergo identical rigorous peer review by cardiovascular specialists.

Research Scope

Hypertension, blood pressure regulation, cardiovascular outcomes, antihypertensive therapy, and vascular research

Article Types

Clinical trials, systematic reviews, observational studies, case reports, and translational research

Expert Reviewers

Board-certified cardiologists and hypertension specialists with clinical expertise

Why Researchers Choose Membership

Publishing cardiovascular research should improve patient outcomes and advance clinical practice, not create financial barriers or publication uncertainty. Hypertension researchers and cardiologists face unique publication challenges in the scholarly landscape that our membership program directly addresses. Many investigators struggle with unpredictable costs that complicate grant budgets, review timelines that delay sharing important clinical findings with treating physicians, and limited visibility when critical evidence remains behind paywalls that other clinicians cannot access. Our program provides comprehensive solutions.

Eliminate Cost Uncertainty

"Grant budgets are tight and I cannot predict publishing costs until acceptance."
Lock in predictable annual costs with up to 45% APC savings through membership.

Accelerate Publication

"Important trial results need rapid dissemination to benefit patients."
Streamlined submission with responsive editorial support and clear timelines.

Reach Clinical Community

"My clinical evidence sits behind paywalls that treating physicians cannot access."
Full open access ensures cardiologists worldwide can implement your findings.

Expert Peer Review

"I need reviewers who understand cardiovascular research methodology."
Cardiovascular specialists ensure rigorous, clinically relevant peer review feedback.

Membership Tiers

Select the tier that matches your publication volume and institutional needs. Whether you are an individual cardiologist conducting hypertension research and clinical trials, a graduate student developing expertise in cardiovascular physiology and vascular biology, an academic medical center supporting multiple cardiovascular researchers, or a pharmaceutical company developing antihypertensive therapeutics, our membership tiers provide meaningful cost savings and dedicated author support throughout the entire publication lifecycle.

Student

$3,200/yr $2,080 per year
  • Unlimited submissions
  • Primary/co-author eligible
  • CV certificate
  • Compliance guidance
  • Requires advisor letter
  • 2-year option: $2,405

Institutional

$9,500 per year
  • 20 manuscripts APC waiver
  • Departmental sharing
  • Centralized billing
  • Platform recognition
  • Onboarding support
  • 2-year: $11,500 (30)

Corporate

$5,600/yr $3,640 for 10 articles
  • 10 staff manuscripts/year
  • Themed issue contributions
  • Recognition certificate
  • Same review standards
  • Stakeholder recognition
  • 2-year: $4,225 (15/yr)

Submit Your Research

Two convenient pathways to share your blood pressure research with the global cardiovascular community.

ManuscriptZone Portal

Full-featured online submission system with real-time tracking, reviewer communication, and comprehensive revision management tools.

Submit via ManuscriptZone

Simple Submission Form

Quick and direct manuscript upload with essential metadata collection for straightforward submissions.

Submit via Form

How to Apply

Ready to join the growing community of cardiovascular researchers benefiting from membership? Email [email protected] to begin your application. Our dedicated membership team responds within 48 hours with detailed next steps and pricing confirmation for your selected tier.

1

Contact Us

Send your name, institutional affiliation, and desired membership tier

2

Confirm Details

We verify eligibility and confirm final pricing details

3

Complete Payment

Secure invoice processing with flexible payment options

4

Start Publishing

Submit your manuscripts with all membership benefits active

Important Terms

+

Membership benefits apply during active term and do not roll over unless specified in writing.

+

Early renewal before expiration qualifies for a 20% discount on renewal fees.

+

APC relief applies after peer review and formal acceptance, not upon submission.

+

Membership does not guarantee acceptance; all manuscripts undergo standard expert review.

Editorial Independence: Membership reduces publication costs but never influences peer review outcomes or acceptance decisions. Every manuscript submitted to our journal is evaluated on scientific merit, clinical significance, and methodological rigor alone. Our distinguished cardiovascular peer reviewers apply identical standards to all submissions regardless of membership status. The editorial team operates completely independently from membership administration to maintain scholarly integrity.

Common Questions

Do rejected manuscripts use my membership benefits?

No. APC waivers and membership benefits apply only to manuscripts that successfully complete the full peer review process and receive formal acceptance from our editorial team.

Can co-authors use my membership?

Yes. All co-authors listed on your cardiovascular manuscripts receive full APC relief within your membership allowance, making collaborative multi-center clinical research highly cost-effective for your team.

Are special issues included?

Unlimited submission benefits exclude special issues, but members receive a generous 30% discount on all special issue APCs.

Can I upgrade my tier later?

Absolutely. Contact our dedicated membership team anytime to upgrade your tier and receive a revised agreement reflecting your new benefits.

Advance Blood Pressure Research Today

Remove publication barriers and financial uncertainty. Reach cardiologists and hypertension specialists worldwide. Accelerate critical breakthroughs in hypertension management and improved cardiovascular patient outcomes.